z-logo
open-access-imgOpen Access
Chemokine CCL1 as a therapeutic target for pulmonary fibrosis: comments onThe chemokine CCL1 triggers an AMFR‒SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis
Author(s) -
Shanshan Liu,
Chang Liu,
Zhuowei Hu,
Yang Xiao
Publication year - 2021
Publication title -
journal of molecular cell biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.825
H-Index - 62
eISSN - 1674-2788
pISSN - 1759-4685
DOI - 10.1093/jmcb/mjab080
Subject(s) - chemokine , myofibroblast , pulmonary fibrosis , cancer research , fibrosis , biology , medicine , microbiology and biotechnology , immunology , inflammation , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom